Printer Friendly

BERGEN BRUNSWIG ANNOUNCES EXPIRATION OF WAITING PERIOD; SENDS LETTER TO DURR-FILLAUER REQUESTING INFORMATION

 BERGEN BRUNSWIG ANNOUNCES EXPIRATION OF WAITING PERIOD;

 SENDS LETTER TO DURR-FILLAUER REQUESTING INFORMATION
 ORANGE, Calif., July 23 /PRNewswire/ -- Bergen Brunswig Corporation (AMEX: BBC) announced today that the waiting period under the Hart- Scott-Rodino Antitrust Improvements Act applicable to the pending cash tender offer by its wholly owned subsidiary, BBC Acquisition Corp., for all outstanding shares of common stock of Durr-Fillauer Medical, Inc. (NASDAQ: DUFM), has expired.
 Bergen Brunswig also announced that it has sent the following letter from its chairman and chief executive officer, Robert E. Martini, to the board of directors of Durr-Fillauer:
 On July 7, when we submitted to you our written proposal to acquire all of the outstanding shares of common stock of Durr-Fillauer at $26 per share in cash, we also requested that you furnish us the same information made available to Cardinal Distribution. As should have been obvious to you, we requested this information in order to be in a position to determine whether higher values for Durr-Fillauer could be justified than those warranted by the publicly available information on which we have been forced to rely. To underscore this point, we also stressed our willingness to negotiate all aspects of our proposal, which already represented a significant premium over the market valuation of your original transaction with Cardinal. In addition, we stated that we and our advisors were standing ready to meet with you and your advisors at your earliest convenience.
 On July 17, we reconfirmed our flexibility as to all aspects of our proposal and specifically cautioned you against taking actions designed to or having the effect of placing additional impediments in the path of acceptance of our proposal by your stockholders.
 Notwithstanding our communications, you chose simply to ignore us. You have not provided us with one shred of information. Instead, despite our July 17 letter renewing our request for the information and cautioning you not to do so, you secretly negotiated a new acquisition agreement with Cardinal, attempted to lock it up by interposing a significantly increased "break-up" fee, and rejected our proposal without so much as an attempt to contact us. In doing so, you have denied us a level playing field and neglected the best interests of your stockholders. In our view, such behavior is clearly unlawful.
 Despite these obstacles which you have chosen to place in our path, we are still very serious about our proposal. However, before we can consider increasing our purchase price, we must receive the same information you provided to Cardinal. Accordingly, we again request that you give us full access to all information regarding Durr-Fillauer provided to Cardinal or its representatives. This information of course would include the internal financial analyses and forecasts prepared by Durr-Fillauer which have been described as having been reviewed by your and Cardinal's financial advisors and which we must assume were instrumental in convincing Cardinal to so significantly enhance its proposed purchase price for Durr-Fillauer. To assure you of our good faith in requesting this information, we are prepared to sign and abide by an appropriate form of confidentiality agreement, a copy of which is included with this letter.
 We believe you have a clear fiduciary obligation to furnish us with our requested information promptly. We hereby are asking that you advise us by 12:00 noon, New York City time, on Friday, July 24, 1992, whether you intend to comply with our request and, if so, provide us with details on when and where information will be made available to us. If you fail to respond to us by noon on Friday or reject our request, we will take appropriate steps to compel you to comply with your legal obligations.
 Once again, we and our advisors are prepared to meet with you and your advisors at any time and urge you to contact us promptly.
 /end of letter/
 -0- 7/23/92
 /CONTACT: Neil F. Dimick, executive vice president and chief financial officer of Bergen Brunswig, 714-385-4000/
 (BBC DUFM) CO: Bergen Brunswig Corporation; Durr-Fillauer Medical, Inc. ST: California, Alabama IN: MTC SU:


GK-OS -- NY019 -- 2348 07/23/92 09:48 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 23, 1992
Words:684
Previous Article:NEW DIMENSIONS IN MEDICINE RENEGOTIATES DISTRIBUTION AGREEMENT
Next Article:SUN COMPANY REPORTS 1992 SECOND QUARTER AND SIX-MONTH EARNINGS
Topics:


Related Articles
COMMTRON/INGRAM INFORMATION STATEMENT MAILED; BBC 6-7/8 PERCENT SUBORDINATED EXCHANGEABLE DEBENTURES TO REMAIN OUTSTANDING
CARDINAL DISTRIBUTION ANNOUNCES AGREEMENT TO ACQUIRE DURR DRUG COMPANY
BERGEN BRUNSWIG ANNOUNCES COMPLETION OF SALE OF COMMTRON TO INGRAM
BERGEN BRUNSWIG EXTENDS OFFER FOR DURR-FILLAUER
BERGEN BRUNSWIG INCREASES BID FOR DURR-FILLAUER
BERGEN BRUNSWIG SENDS LETTER TO DURR-FILLAUER MEDICAL BOARD
BERGEN BRUNSWIG TO ACQUIRE DR. T.C. SMITH CO.
BERGEN BRUNSWIG ADDS TO MEDICAL SUPPLY BUSINESS WITH ACQUISITION OF SOUTHEAST HOSPITAL SUPPLY GROUP
BERGEN BRUNSWIG SIGNS AGREEMENT TO ACQUIRE $45 MILLION MED-SURG DISTRIBUTOR
BERGEN BRUNSWIG ANNOUNCES COMPLETION OF BIDDLE & CROWTHER ACQUISITION

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters